CBHA is a family of hybrid polar compounds that inhibit histone deacetylase, and induces growth inhibition, cell cycle arrest and apoptosis in human endometrial and ovarian cancer cells.

Takai N, Ueda T, Nishida M, Nasu K, Matsuda K, Kusumoto M, Narahara H

Open source

DOI
10.1159/000092585
Published
2006
Container
Oncology
Publisher
Not recorded
Open access
unknown

Credibility signals

serious concern Score 8/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1159/000092585,
  title = {CBHA is a family of hybrid polar compounds that inhibit histone deacetylase, and induces growth inhibition, cell cycle arrest and apoptosis in human endometrial and ovarian cancer cells.},
  author = {Takai N and Ueda T and Nishida M and Nasu K and Matsuda K and Kusumoto M and Narahara H},
  year = {2006},
  journal = {Oncology},
  doi = {10.1159/000092585},
  url = {https://doi.org/10.1159/000092585}
}

RIS

TY  - JOUR
TI  - CBHA is a family of hybrid polar compounds that inhibit histone deacetylase, and induces growth inhibition, cell cycle arrest and apoptosis in human endometrial and ovarian cancer cells.
AU  - Takai N
AU  - Ueda T
AU  - Nishida M
AU  - Nasu K
AU  - Matsuda K
AU  - Kusumoto M
AU  - Narahara H
PY  - 2006
JO  - Oncology
DO  - 10.1159/000092585
UR  - https://doi.org/10.1159/000092585
ER  - 

APA

N, T., T, U., M, N., K, N., K, M., M, K., & H, N. (2006). CBHA is a family of hybrid polar compounds that inhibit histone deacetylase, and induces growth inhibition, cell cycle arrest and apoptosis in human endometrial and ovarian cancer cells.. Oncology. https://doi.org/10.1159/000092585

Source records